Some features of blood pressure variability in patients with arterial hypertension in various modes of antihypertensive therapy
DOI:
https://doi.org/10.14739/2310-1210.2020.3.204881Keywords:
arterial hypertension, chronotherapy, blood pressure variability, ambulatory blood pressure monitoringAbstract
Aim. The study objective was to compare different timing modes of hypertension medications dosing in patients with arterial hypertension in relation to blood pressure level and variability.
Materials and methods. The study included 103 subjects with previously diagnosed AH in whom 24h ambulatory blood pressure monitoring records of adequate quality were obtained. Participants were stratified to three groups based on timing of hypertension medications dosing – morning dosing (group 1), bedtime dosing (group 2), and as needed (group 3). The last one included patients with low compliance of prescribed medications and irregular antihypertensive drugs intake. The systolic and diastolic blood pressure variability indices – standard deviation (VAR1) and root-mean-square value of the difference between consecutive blood pressure measurements (VAR2) were calculated. The Kruskal-Wallis ANOVA or χ2-test, as appropriate, was used to compare the groups. A two-sided P value <0.05 was considered statistically significant. Analysis of data included corrections for multiple comparisons.
Results. Statistically significant differences were found in mean 24-h diastolic blood pressure values between groups 1 and 3, 2 and 3 (P = 0.02), awake mean diastolic blood pressure values between groups 1 and 3 (P = 0.03) and for VAR1 night-time systolic blood pressure between groups 1 and 3, 2 and 3 (P < 0.05). There were no significant differences between any of the studied parameters between the groups with the morning and evening dosing of antihypertensive drugs.
Conclusions. Treatment mode does not significantly affect the short-term variability of blood pressure, determined by the standard deviation from the mean blood pressure and the root-mean-square value of the difference between consecutive blood pressure measurements for a given time period.
References
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016). Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet, 387(10022), 957-967. https://doi.org/10.1016/s0140-6736(15)01225-8
Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., Abdollahpour, I., Abdulkader, R. S., Abebe, M., Abebe, Z., Abera, S. F., Abil, O. Z., Abraha, H. N., … Murray, C. J. L. (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1923-1994. https://doi.org/10.1016/s0140-6736(18)32225-6
Beaney, T., Burrell, L. M., Castillo, R. R., Charchar, F. J., Cro, S., Damasceno, A., Kruger, R., Nilsson, P. M., Prabhakaran, D., Ramirez, A. J., Schlaich, M. P., Schutte, A. E., Tomaszewski, M., Touyz, R., Wang, J.-G., Weber, M. A., Poulter, N. R., Burazeri, G., Qirjako, G., … Xia, X. (2019). May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. European Heart Journal, 40(25), 2006-2017. https://doi.org/10.1093/eurheartj/ehz300
Niiranen, T. J., Mäki, J., Puukka, P., Karanko, H., & Jula, A. M. (2014). Office, Home, and Ambulatory Blood Pressures as Predictors of Cardiovascular Risk. Hypertension, 64(2), 281-286. https://doi.org/10.1161/hypertensionaha.114.03292
American Diabetes Association (2018). 9. Cardiovascular Disease and Risk Management:Standards of Medical Care in Diabetes - 2018. Diabetes Care, 41(Suppl. 1), S86-S104. https://doi.org/10.2337/dc18-s009
Hermida, R. C., Ayala, D. E., Fernández, J. R., Mojón, A., & Smolensky, M. H. (2018). Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. European Journal of Clinical Investigation, 48(5), Article e12909. https://doi.org/10.1111/eci.12909
Bowles, N. P., Thosar, S. S., Herzig, M. X., & Shea, S. A. (2018). Chronotherapy for Hypertension. Current Hypertension Reports, 20(11). https://doi.org/10.1007/s11906-018-0897-4
Zawadzki, M. J., Small, A. K., & Gerin, W. (2017). Ambulatory blood pressure variability. Blood Pressure Monitoring, 22(2), 53-58. https://doi.org/10.1097/mbp.0000000000000230
Weber, M. A. (2017). Blood pressure variability and cardiovascular prognosis: implications for clinical practice. European Heart Journal, 38(37), 2823-2826. https://doi.org/10.1093/eurheartj/ehx322
Chowdhury, E. K., Wing, L. M. H., Jennings, G. L. R., Beilin, L. J., & Reid, C. M. (2018). Visit-to-visit (long-term) and ambulatory (short-term) blood pressure variability to predict mortality in an elderly hypertensive population. Journal of Hypertension, 36(5), 1059-1067. https://doi.org/10.1097/hjh.0000000000001652
Hermida, R. C., Smolensky, M. H., Ayala, D. E., Portaluppi, F., Crespo, J. J., Fabbian, F., Haus, E., Manfredini, R., Mojón, A., Moyá, A., Piñeiro, L., Ríos, M. T., Otero, A., Balan, H., & Fernández, J. R. (2013). 2013 Ambulatory Blood Pressure Monitoring Recommendations for the Diagnosis of Adult Hypertension, Assessment of Cardiovascular and other Hypertension-associated Risk, and Attainment of Therapeutic Goals. Chronobiology International, 30(3), 355-410. https://doi.org/10.3109/07420528.2013.750490
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., Kerins, M., Kjeldsen, S. E., Kreutz, R., Laurent, S., … Brady, A. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021-3104. https://doi.org/10.1093/eurheartj/ehy339
Head, G. A. (2014). Ambulatory Blood Pressure Monitoring Is Ready to Replace Clinic Blood Pressure in the Diagnosis of Hypertension. Hypertension, 64(6), 1175-1181. https://doi.org/10.1161/hypertensionaha.114.03882
Pickering, T. G., Gerin, W., & Schwartz, A. R. (2002). What is the white-coat effect and how should it be measured? Blood Pressure Monitoring, 7(6), 293-300. https://doi.org/10.1097/00126097-200212000-00001
Gorostidi, M., Vinyoles, E., Banegas, J. R., & de la Sierra, A. (2014). Prevalence of white-coat and masked hypertension in national and international registries. Hypertension Research, 38(1), 1-7. https://doi.org/10.1038/hr.2014.149
Pickering, T. G., Eguchi, K., & Kario, K. (2007). Masked Hypertension: A Review. Hypertension Research, 30(6), 479-488. https://doi.org/10.1291/hypres.30.479
Banegas, J. R., Ruilope, L. M., de la Sierra, A., de la Cruz, J. J., Gorostidi, M., Segura, J., Martell, N., Garcia-Puig, J., Deanfield, J., & Williams, B. (2014). High prevalence of masked uncontrolled hypertension in people with treated hypertension. European Heart Journal, 35(46), 3304-3312. https://doi.org/10.1093/eurheartj/ehu016
Sun, Y., Yu, X., Liu, J., Zhou, N., Chen, L., Zhao, Y., Li, X., Wang, J., & Cui, L. (2016). Effect of bedtime administration of blood-pressure lowering agents on ambulatory blood pressure monitoring results: A meta-analysis. Cardiology Journal, 23(4), 473-481. https://doi.org/10.5603/cj.a2016.0027
Carter, B. L., Chrischilles, E. A., Rosenthal, G., Gryzlak, B. M., Eisenstein, E. L., & Vander Weg, M. W. (2013). Efficacy and Safety of Nighttime Dosing of Antihypertensives: Review of the Literature and Design of a Pragmatic Clinical Trial. The Journal of Clinical Hypertension, 16(2), 115-121. https://doi.org/10.1111/jch.12238
Vishram, J. K. K., Dahlöf, B., Devereux, R. B., Ibsen, H., Kjeldsen, S. E., Lindholm, L. H., Mancia, G., Okin, P. M., Rothwell, P. M., Wachtell, K., & Olsen, M. H. (2015). Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage. Journal of Hypertension, 33(12), 2422-2430. https://doi.org/10.1097/hjh.0000000000000739
Gosmanova, E. O., Mikkelsen, M. K., Molnar, M. Z., Lu, J. L., Yessayan, L. T., Kalantar-Zadeh, K., & Kovesdy, C. P. (2016). Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease. Journal of the American College of Cardiology, 68(13), 1375-1386. https://doi.org/10.1016/j.jacc.2016.06.054
Mehlum, M. H., Liestøl, K., Kjeldsen, S. E., Julius, S., Hua, T. A., Rothwell, P. M., Mancia, G., Parati, G., Weber, M. A., & Berge, E. (2018). Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. European Heart Journal, 39(24), 2243-2251. https://doi.org/10.1093/eurheartj/ehx760
Stevens, S. L., Wood, S., Koshiaris, C., Law, K., Glasziou, P., Stevens, R. J., & McManus, R. J. (2016). Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. British Medical Journal, 354, Article i4098. https://doi.org/10.1136/bmj.i4098
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
